Search contract descriptions, companies and agencies.
ISSUE ADVANCED AGREEMENT PRIOR TO AWARD OF AN OTHER TRANSACTION AGREEMENT (OTA)FOR THE
COVID19 VACCINE DEVELOPMENT AND MANUFACTURING
Total Committed
$413M
Product or Service Description
Biomedical Advanced Development R&D
Total Potential Value
$413M
Contracting Agency
Effective Date
May 20, 2020
Funding Department
OFFICE OF ACQ MGMT POLICY
Type
Cost no fee
Solicitation Procedure
Negotiated proposal/quote
Extent Competed
Full and open competition
Recent Contract Actions 
Contracts can have multiple “contract actions”: This is how agencies spend money for a specific purpose, adjust the amount committed or change the contract in a way that doesn’t affect the amount. That last scenario is usually indicated by a $0 action. If there is a contract action for a negative amount, it generally means the contract was adjusted or canceled.
| Vendor | Description | Signed | Reason for Change | Amount Committed |
|---|---|---|---|---|
| ASTRAZENECA PHARMACEUTICALS LP | CHANGE IN OTAO AND OTAS OF ADVANCED AGREEMENT FOR THE COVID19 VACCINE DEVELOPMENT AND MANUFACTURING | Oct. 21, 2020 | Change Order | $0 |
| ASTRAZENECA PHARMACEUTICALS LP | CHANGE IN OTAO AND OTAS OF ADVANCED AGREEMENT FOR THE COVID19 VACCINE DEVELOPMENT AND MANUFACTURING | Oct. 15, 2020 | Change Order | $0 |
| ASTRAZENECA PHARMACEUTICALS LP | CHANGE IN OTAO AND OTAS OF ADVANCED AGREEMENT FOR THE COVID19 VACCINE DEVELOPMENT AND MANUFACTURING | Oct. 5, 2020 | Other Administrative Action | $0 |
| ASTRAZENECA PHARMACEUTICALS LP | THIRD NO-COST EXTENSION FOR EXPIRATION OF ADVANCED AGREEMENT FOR THE COVID19 VACCINE DEVELOPMENT AND MANUFACTURING | Sept. 30, 2020 | Other Administrative Action | $0 |
| ASTRAZENECA PHARMACEUTICALS LP | EXTEND FOR EXPIRATION OF ADVANCED AGREEMENT FOR THE COVID19 VACCINE DEVELOPMENT AND MANUFACTURING | Sept. 15, 2020 | Other Administrative Action | $0 |
| ASTRAZENECA PHARMACEUTICALS LP | ISSUE EXTENSION OF TARGET DATE OF DEFINITIZATION OF ADVANCED AGREEMENT FOR OTHER TRANSACTION AGREEMENT (OTA)FOR THE COVID19 VACCINE DEVELOPMENT AND MANUFACTURING | Aug. 25, 2020 | Other Administrative Action | $0 |
| ASTRAZENECA PHARMACEUTICALS LP | ISSUE ADVANCED AGREEMENT PRIOR TO AWARD OF AN OTHER TRANSACTION AGREEMENT (OTA)FOR THE COVID19 VACCINE DEVELOPMENT AND MANUFACTURING | May 20, 2020 | $413,200,000 |
About this data
This data comes from the Federal Procurement Data System, which includes all contracts worth $10,000 or more. We look at all contracts that are tagged with the procurement code for COVID-19 or otherwise started in 2020 and contain “COVID-19” in the description. Department of Defense contracting data is subject to a 90-day delay before it appears in the data.